Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.
Ankyra has raised $45.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Ankyra's investors include Sands Capital Ventures, Polaris Partners, Fidelity, Mithril Capital Management, Spring Mountain Capital.
Ankyra is headquartered in Boston, United States.
Ankyra is a biotech company developing anchored immunotherapy for cancer treatments.
Ankyra is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ankyra — Funding & Investors." VCBacked, November 12, 2021, https://www.vcbacked.co/company/ankyra. Accessed August 14, 2026.
VCBacked. (2021). Ankyra — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ankyra
{{cite web |title=Ankyra — Funding & Investors |url=https://www.vcbacked.co/company/ankyra |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated